ATE500270T1 - Materialien und methoden die sich auf g-protein gekoppelte rezeptor oligomere beziehen - Google Patents

Materialien und methoden die sich auf g-protein gekoppelte rezeptor oligomere beziehen

Info

Publication number
ATE500270T1
ATE500270T1 AT04733584T AT04733584T ATE500270T1 AT E500270 T1 ATE500270 T1 AT E500270T1 AT 04733584 T AT04733584 T AT 04733584T AT 04733584 T AT04733584 T AT 04733584T AT E500270 T1 ATE500270 T1 AT E500270T1
Authority
AT
Austria
Prior art keywords
coupled receptor
protein coupled
materials
methods related
oligomers
Prior art date
Application number
AT04733584T
Other languages
English (en)
Inventor
Graeme Davidson Milligan
Dominic Behan
Original Assignee
Univ Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Glasgow filed Critical Univ Glasgow
Application granted granted Critical
Publication of ATE500270T1 publication Critical patent/ATE500270T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04733584T 2003-05-20 2004-05-18 Materialien und methoden die sich auf g-protein gekoppelte rezeptor oligomere beziehen ATE500270T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47202503P 2003-05-20 2003-05-20
PCT/GB2004/002150 WO2004104041A1 (en) 2003-05-20 2004-05-18 Materials and methods relating to g-protein coupled receptor oligomers

Publications (1)

Publication Number Publication Date
ATE500270T1 true ATE500270T1 (de) 2011-03-15

Family

ID=33476913

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04733584T ATE500270T1 (de) 2003-05-20 2004-05-18 Materialien und methoden die sich auf g-protein gekoppelte rezeptor oligomere beziehen

Country Status (11)

Country Link
US (2) US7405053B2 (de)
EP (1) EP1625159B1 (de)
JP (1) JP4932486B2 (de)
CN (1) CN1809587B (de)
AT (1) ATE500270T1 (de)
AU (1) AU2004241193B2 (de)
CA (1) CA2525286C (de)
DE (1) DE602004031605D1 (de)
MX (1) MXPA05012546A (de)
TW (1) TWI334871B (de)
WO (1) WO2004104041A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006011133A1 (de) * 2006-03-10 2007-09-13 Raumedic Ag Chimäres Polypeptidmolekül
CA3009680C (en) 2006-03-16 2023-08-15 Symthera Canada Ltd. Combination of cytokine and cytokine receptor for altering immune system functioning
WO2008014382A2 (en) * 2006-07-26 2008-01-31 Case Western Reserve University System and method for controlling g-protein coupled receptor pathways
EP2605015A1 (de) * 2006-11-10 2013-06-19 Dimerix Bioscience Pty.Ltd. Kits zur Bestimmung der Wechselwirkung einer Testverbindung mit zwei miteinander assozierten Rezeptoren
AU2008228085B2 (en) * 2007-03-22 2011-12-08 Nxera Pharma Uk Limited Mutant G-protein coupled receptors and methods for selecting them
EP2048503A1 (de) * 2007-10-09 2009-04-15 Universität Konstanz Prüfung zur Überwachung der Aktivität von Frizzled-Rezeptoren
TWI426459B (zh) * 2007-10-26 2014-02-11 Hon Hai Prec Ind Co Ltd 自動識別模具出庫和入庫動作的系統及方法
WO2010003170A1 (en) * 2008-06-17 2010-01-14 Dimerix Bioscience Pty Ltd Novel receptor hetero-dimers/-oligomers
WO2010002468A1 (en) * 2008-07-01 2010-01-07 The Trustees Of Columbia University In The City Of New York A functional complementation assay for defined gpcr oligomers
WO2010031114A1 (en) * 2008-09-18 2010-03-25 Dimerix Bioscience Pty Ltd Novel receptor hetero-dimers/-oligomers
US20100120063A1 (en) * 2008-10-10 2010-05-13 Discoverx Corporation GPCR Arrestin Assays
CA2756743A1 (en) * 2009-03-27 2010-09-30 Dimerix Bioscience Pty Ltd. Novel receptor hetero-dimers/-oligomers
WO2015128894A1 (ja) * 2014-02-25 2015-09-03 国立大学法人東北大学 Ｇタンパク質共役型受容体のシグナル伝達の検出方法
JP7517986B2 (ja) 2017-12-19 2024-07-17 ジーピーシーアール セラピューティクス，インク． Ｇｐｃｒヘテロマー阻害剤及びその用途
CN112639102B (zh) * 2018-08-29 2024-03-01 南京传奇生物科技有限公司 抗间皮素嵌合抗原受体(car)构建体及其用途
EP3828543B1 (de) * 2018-09-05 2024-04-03 Yamasa Corporation Verfahren und kit zur schnellen messung der autoantikörperaktivität in bezug auf tsh-rezeptor
WO2020117752A1 (en) * 2018-12-04 2020-06-11 The University Of North Carolina At Chapel Hill G protein-coupled receptor screening systems

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462856A (en) 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
US7119190B2 (en) 1997-04-14 2006-10-10 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human G protein-coupled receptors
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
CA2279881C (en) 1997-04-14 2009-12-22 Dominic P. Behan A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US6365356B1 (en) 1999-03-17 2002-04-02 Cornell Research Foundation, Inc. Receptors that regulate cell signaling relating to chemokines
US20020137054A1 (en) 1999-11-02 2002-09-26 Smithkline Beecham Corporation & Smithkline Beecham Plc AXOR35, a G-protein coupled receptor
US20010053848A1 (en) 2000-03-10 2001-12-20 Patel Yogesh C. Hetero-oligomeric G protein-coupled receptors as novel drug targets
PL374875A1 (en) 2002-07-25 2005-11-14 Aclara Biosciences, Inc. Detecting receptor oligomerization

Also Published As

Publication number Publication date
AU2004241193B2 (en) 2011-03-10
JP2007537707A (ja) 2007-12-27
CA2525286C (en) 2012-09-11
EP1625159B1 (de) 2011-03-02
JP4932486B2 (ja) 2012-05-16
US20070099263A1 (en) 2007-05-03
CN1809587B (zh) 2010-11-10
AU2004241193A1 (en) 2004-12-02
TWI334871B (en) 2010-12-21
US20080286828A1 (en) 2008-11-20
DE602004031605D1 (de) 2011-04-14
EP1625159A1 (de) 2006-02-15
CA2525286A1 (en) 2004-12-02
TW200510456A (en) 2005-03-16
MXPA05012546A (es) 2006-05-25
WO2004104041A1 (en) 2004-12-02
CN1809587A (zh) 2006-07-26
US7741064B2 (en) 2010-06-22
US7405053B2 (en) 2008-07-29

Similar Documents

Publication Publication Date Title
ATE500270T1 (de) Materialien und methoden die sich auf g-protein gekoppelte rezeptor oligomere beziehen
DE602005021811D1 (de) Multimere konstrukte
MY169472A (en) Refolding of recombinant proteins
DK1532261T3 (da) Fremgangsmåder og DNA-konstrukter til produktion af polypeptider med højt udbytte
ATE514783T1 (de) Plasmidsystem zur expression mehrerer gene
DE602006021520D1 (de) Rekombinante Polypeptide auf Triplex-Gerüst-Basis
AR065373A1 (es) Proteinas de fusion de inmunoglobulina y metodos de elaboracion
ATE484591T1 (de) Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression
BRPI0413426A (pt) antagonistas de receptor novo
DE60332993D1 (de) Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung
DE60324331D1 (de) Millisekunden-aktivationsschalter für 7-transmembran-proteine
ATE532861T1 (de) Expressionsvektor
DE602005023811D1 (de) Nukleinsäurekonstruct, Expressionsvektor und Verfahren zur Steigerung der Hergestellten Menge von rekombinantem Eiweiss
DE60333254D1 (de) Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung
DE60325552D1 (de) Alkoxysilylfunktionelle materialien auf siliconbasis
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
WO2008002548A3 (en) Novel human acidic mammalian chitinase and use thereof
DE60333001D1 (de) Vac-bac-shuttlevektor-system
DE60117788D1 (de) Menschliche wingless-änhliche gene
CY1105820T1 (el) Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις
KR100717353B1 (ko) 피키아 파스토리스 유래의 자동 유도성 ｎｐｓ 프로모터 및이를 이용한 이종 단백질의 제조방법
ATE353969T1 (de) Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
Wall The three-dimensional structure of a G protein heterotrimer.
ATE445161T1 (de) Rekombinantes zellsystem zur deorphanisierung von g protein-gekoppelten rezeptoren
WO2004075725A3 (en) Bcrm-1 genes and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties